Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suman Kumar Ray

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Current Molecular Medicine|January 13, 2022
Altered Expression of TRIM Proteins - Inimical Outcome and Inimitable Oncogenic Function in Breast Cancer with Diverse Carcinogenic HallmarksSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|April 25, 2022
The Emergence of Omicron SARS-CoV-2 Variant (B.1.1.529): The Latest Episode in the COVID-19 Pandemic with a Global RiposteSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|October 28, 2022
Interplay between SARS-CoV-2 and Cancer: Plausible Risk Factors, Cellular Immune Responses, Cancer Directed Therapy- Current ChallengesSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|June 28, 2024
Exploring New COVID-19 Incertitude: JN.1 Variant- JN.1: The Queer Bird among Omicron SublineagesSuman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|May 13, 2022
Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic PotentialSuman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|May 16, 2022
Hypoxia-Inducible Factors-Based Single Nucleotide Polymorphism in Breast Cancer with More Cancer SusceptibilitySuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|June 7, 2022
Divulging Incipient SARS-CoV-2 Delta (B.1.617.2) Variant: Possible Interference with Global ScenarioSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|April 27, 2023
Human Monkeypox Virus: Current State of Knowledge and Implications for the Imminent DaysSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|March 2, 2023
Can the New BA.2.75 Sub-variant Lead To One More COVID-19 Wave?Suman Kumar Ray, Sukhes Mukherjee
Current Neuropharmacology|August 12, 2022
Neuropharmacology of Alcohol Addiction with Special Emphasis on Proteomic Approaches for Identification of Novel Therapeutic TargetsSuman Kumar Ray, Sukhes Mukherjee
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Current Molecular Medicine|January 13, 2022
Altered Expression of TRIM Proteins - Inimical Outcome and Inimitable Oncogenic Function in Breast Cancer with Diverse Carcinogenic HallmarksSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|April 25, 2022
The Emergence of Omicron SARS-CoV-2 Variant (B.1.1.529): The Latest Episode in the COVID-19 Pandemic with a Global RiposteSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|October 28, 2022
Interplay between SARS-CoV-2 and Cancer: Plausible Risk Factors, Cellular Immune Responses, Cancer Directed Therapy- Current ChallengesSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|June 28, 2024
Exploring New COVID-19 Incertitude: JN.1 Variant- JN.1: The Queer Bird among Omicron SublineagesSuman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|May 13, 2022
Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic PotentialSuman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|May 16, 2022
Hypoxia-Inducible Factors-Based Single Nucleotide Polymorphism in Breast Cancer with More Cancer SusceptibilitySuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|June 7, 2022
Divulging Incipient SARS-CoV-2 Delta (B.1.617.2) Variant: Possible Interference with Global ScenarioSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|April 27, 2023
Human Monkeypox Virus: Current State of Knowledge and Implications for the Imminent DaysSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|March 2, 2023
Can the New BA.2.75 Sub-variant Lead To One More COVID-19 Wave?Suman Kumar Ray, Sukhes Mukherjee
Current Neuropharmacology|August 12, 2022
Neuropharmacology of Alcohol Addiction with Special Emphasis on Proteomic Approaches for Identification of Novel Therapeutic TargetsSuman Kumar Ray, Sukhes Mukherjee
Pageof 8